Ralph Alvarez - 20 Jul 2026 Form 4 Insider Report for ELI LILLY & Co (LLY)

Reporting relationship: Director
Issuer ticker: LLY
Reported as of: 20 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 21 Jul 2026, 16:37:50 UTC
Prior SEC filing: 16 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Jonathan Groff for Ralph Alvarez, pursuant to authorization on file

Key filing fact

Ralph Alvarez filed Form 4 for ELI LILLY & Co (LLY) on 21 Jul 2026.

Key facts

This page summarizes Ralph Alvarez's Form 4 filing for ELI LILLY & Co (LLY).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 21 Jul 2026, 16:37.

Change

Previous filing in this sequence was filed on 16 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001310215 Primary reporting owner

Alvarez Ralph

Relationship: Director
Address: LILLY CORPORATE CENTER, INDIANAPOLIS
Signature: /s/ Jonathan Groff for Ralph Alvarez, pursuant to authorization on file
Signature date: 21 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LLY transaction

Common Stock

Award

Transaction value
Shares: +11
Change %: +0.02%
Price: $1146.90^*
Shares after: 55,734
Date: 20 Jul 2026
Ownership: Direct
Footnotes: F1

LLY holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 758
Date: 20 Jul 2026
Ownership: By Trust
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Footnote F2

The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.